Xeljanz xr and Malaise - a phase IV clinical study of FDA data

Summary:

We study 97,746 people who have side effects when taking Xeljanz xr. Malaise is found, especially among people who are female, 60+ old, have been taking the drug for 1 - 6 months, also take Enbrel and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people take Xeljanz xr and have Malaise. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

What are phase IV trials?

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 24, 2023

97,746 people reported to have side effects when taking Xeljanz xr.
Among them, 5,193 people (5.31%) have Malaise.

What is Xeljanz xr?

Xeljanz xr has active ingredients of tofacitinib citrate. Currently, eHealthMe is studying from 97,779 Xeljanz xr users.

What is Malaise?

Malaise (a feeling of general discomfort or uneasiness) is found to be associated with 4,758 drugs and 4,972 conditions by eHealthMe. Currently, we are studying 502,217 people who have Malaise.

Number of Xeljanz xr and Malaise reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Xeljanz xr and have Malaise?

Check whether Malaise is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Malaise and when was it recovered:

Malaise in Xeljanz xr

Expand to all the drugs that have ingredients of tofacitinib citrate:

Malaise and drugs with ingredients of tofacitinib citrate (11,748 reports)

Alternative drugs to, pros and cons of Xeljanz xr:

Xeljanz xr (97,779 reports)

Browse all side effects of Xeljanz xr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Malaise treatments and more:

Malaise (502,217 reports)

Common drugs associated with Malaise:

All the drugs that are associated with Malaise:

Malaise (4,758 drugs)

Common conditions associated with Malaise:

Rheumatoid arthritis: 32,618 reports
Multiple sclerosis: 23,252 reports
High blood pressure: 19,338 reports
Pain: 15,076 reports
Asthma: 14,001 reports

All the conditions that are associated with Malaise:

Malaise (4,972 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tofacitinib citrate (the active ingredients of Xeljanz xr) and Xeljanz xr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.